檢索結果 - David J. Brooks

Refine Results
  1. 1
    Neuroimaging in Parkinson’s disease

    Neuroimaging in Parkinson’s disease 由 David J. Brooks

    出版 2004
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Positron emission tomography and single-photon emission computed tomography in central nervous system drug development

    Positron emission tomography and single-photon emission computed tomography in central nervous system drug development 由 David J. Brooks

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Dopamine agonists: their role in the treatment of Parkinson's disease

    Dopamine agonists: their role in the treatment of Parkinson's disease 由 David J. Brooks

    出版 2000
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Imaging Approaches to Parkinson Disease

    Imaging Approaches to Parkinson Disease 由 David J. Brooks

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

    Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective 由 David J. Brooks

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study

    Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study 由 David J. Brooks

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Imaging synucleinopathies

    Imaging synucleinopathies 由 David J. Brooks, Nicola Tambasco

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Neuropsychopharmacology

    Neuropsychopharmacology 由 W. Wolfgang Fleischhacker, David J. Brooks

    出版 2003
    獲取全文
    Livro
    加到收藏夾
    Saved in:
  9. 9
    Endogenous dopamine release after pharmacological challenges in Parkinson's disease

    Endogenous dopamine release after pharmacological challenges in Parkinson's disease 由 Paola Piccini, Nicola Pavese, David J. Brooks

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Tau imaging in neurodegenerative diseases

    Tau imaging in neurodegenerative diseases 由 Melanie Dani, David J. Brooks, Paul Edison

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    The Cholinergic Brain in Parkinson's Disease

    The Cholinergic Brain in Parkinson's Disease 由 Jacopo Pasquini, David J. Brooks, Nicola Pavese

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Regional changes in [<sup>18</sup>F]dopa metabolism in the striatum in Parkinson's disease

    Regional changes in [<sup>18</sup>F]dopa metabolism in the striatum in Parkinson's disease 由 Paul Morrish, G. V. Sawle, David J. Brooks

    出版 1996
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Clinical and [18F] dopa PET findings in early Parkinson's disease.

    Clinical and [18F] dopa PET findings in early Parkinson's disease. 由 Paul Morrish, G. V. Sawle, David J. Brooks

    出版 1995
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    An [<sup>18</sup>F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease

    An [<sup>18</sup>F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease 由 Paul Morrish, G. V. Sawle, David J. Brooks

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding

    MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding 由 Allan K. Hansen, David J. Brooks, Per Borghammer

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease

    Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease 由 Zhen Fan, Aren Okello, David J. Brooks, Paul Edison

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.

    Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. 由 David J. Burn, G. V. Sawle, David J. Brooks

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Age at onset and Parkinson disease phenotype

    Age at onset and Parkinson disease phenotype 由 Gennaro Pagano, Nicola Ferrara, David J. Brooks, Nicola Pavese

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    An early and late peak in microglial activation in Alzheimer’s disease trajectory

    An early and late peak in microglial activation in Alzheimer’s disease trajectory 由 Zhen Fan, David J. Brooks, Aren Okello, Paul Edison

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    What can biomarkers tell us about cognition in Parkinson's disease?

    What can biomarkers tell us about cognition in Parkinson's disease? 由 Brit Mollenhauer, Lynn Rochester, Alice Chen‐Plotkin, David J. Brooks

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: